Novel EP4 Receptor Agonist-Bisphosphonate Conjugate Drug (C1) Promotes Bone Formation and Improves Vertebral Mechanical Properties in the Ovariectomized Rat Model of Postmenopausal Bone Loss
2015 ◽
Vol 30
(4)
◽
pp. 670-680
◽
Keyword(s):
2015 ◽
Vol 27
(2)
◽
pp. 797-808
◽
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
2002 ◽
Vol 99
(7)
◽
pp. 4580-4585
◽
Keyword(s):
2021 ◽
Vol 2021
◽
pp. 1-12
Keyword(s):
2015 ◽
Vol 100
(8)
◽
pp. 2909-2917
◽
2013 ◽
Vol 20
(11)
◽
pp. 1184-1193
◽